As of 3:59pm ET
| +0.0429 / +7.81%|
The 2 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 4.50, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +659.88% increase from the last price of 0.59.
The current consensus among 4 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.